InnoBioscience is committed to Research, Discovering, and
 
Developing innovative therapies addressing unmet medical needs
  InnoBioscience: Home

 

Corporate Strategy

At InnoBioscience, our corporate strategy includes the following:

Continued research and development of our proprietary auto-immune and Alzheimer disease therapies

Work closely with top research scientists in the field to reduce time, costs and to access government grants for product research and development

Out-licensing technology and intellectual property assets



The company has attracted an outstanding team of scientists, and clinical experts who have been at the forefront of research and development in auto-immune disease, Multiple Screlosis, Rheumatoid Arthritis, Alzheimer Disease, and Duchene Muscular Dystropy. With the depth of experience and expertise in inhalation delivery, InnoBioscience is uniquely positioned to develop a portfolio of its own products to treat patients with these unmet medical needs.